Related references
Note: Only part of the references are listed.Development and Validation of an In Vitro Resazurin-Based Susceptibility Assay against Madurella mycetomatis
S. O. Abd Algaffar et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2021)
Identification of Antiviral Drug Candidates against SARS-CoV-2 from FDA-Approved Drugs
Sangeun Jeon et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
In Vitro Activities of MMV Malaria Box Compounds against the Apicomplexan Parasite Neospora caninum, the Causative Agent of Neosporosis in Animals
Joachim Mueller et al.
MOLECULES (2020)
Repositioning of niclosamide ethanolamine (NEN), an anthelmintic drug, for the treatment of lipotoxicity
Jeong Su Park et al.
FREE RADICAL BIOLOGY AND MEDICINE (2019)
Niclosamide repositioning for treating cancer: Challenges and nano-based drug delivery opportunities
Eduardo Jose Barbosa et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2019)
Niclosamide piperazine prevents high-fat diet-induced obesity and diabetic symptoms in mice
Jingjing Guo et al.
EATING AND WEIGHT DISORDERS-STUDIES ON ANOREXIA BULIMIA AND OBESITY (2019)
Niclosamide, a Drug with Many (Re)purposes
Hachemi Kadri et al.
CHEMMEDCHEM (2018)
Closing the mycetoma knowledge gap
Wendy van de Sande et al.
MEDICAL MYCOLOGY (2018)
Effect of mitochondrial uncouplers niclosamide ethanolamine (NEN) and oxyclozanide on hepatic metastasis of colon cancer
Amer Alasadi et al.
CELL DEATH & DISEASE (2018)
Addressing the most neglected diseases through an open research model: The discovery of fenarimols as novel drug candidates for eumycetoma
Wilson Lim et al.
PLOS NEGLECTED TROPICAL DISEASES (2018)
Niclosamide ethanolamine improves kidney injury in db/db mice
Pengxun Han et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2018)
Mitochondrial uncoupling reveals a novel therapeutic opportunity for p53-defective cancers
R. Kumar et al.
NATURE COMMUNICATIONS (2018)
A phenotypic small-molecule screen identifies halogenated salicylanilides as inhibitors of fungal morphogenesis, biofilm formation and host cell invasion
Carlos Garcia et al.
SCIENTIFIC REPORTS (2018)
Novel anti-staphylococcal and anti-biofilm properties of two anti-malarial compounds: MMV665953 {1-(3-chloro-4-fluorophenyl)-3-(3,4-dichlorophenyl)urea} and MMV665807 {5-chloro-2-hydroxy-N-[3-(trifluoromethyl)phenyl]benzamide}
Marta Zapotoczna et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2017)
Cherchez l'Electron
Pascal Maeser
MOLECULAR MICROBIOLOGY (2017)
Niclosamide ethanolamine inhibits artery constriction
Shan-Liang Li et al.
PHARMACOLOGICAL RESEARCH (2017)
Development of a movement-based in vitro screening assay for the identification of new anti-cestodal compounds
Dominic Ritler et al.
PLOS NEGLECTED TROPICAL DISEASES (2017)
Niclosamide: Beyond an antihelminthic drug
Wei Chen et al.
CELLULAR SIGNALLING (2017)
The Prevalence of Trypanosoma cruzi, the Causal Agent of Chagas Disease, in Texas Rodent Populations
Adriana Aleman et al.
ECOHEALTH (2017)
Drug repositioning approaches to parasitic diseases: a medicinal chemistry perspective
Leonardo G. Ferreira et al.
DRUG DISCOVERY TODAY (2016)
Mycetoma: a unique neglected tropical disease
Eduard E. Zijlstra et al.
LANCET INFECTIOUS DISEASES (2016)
Screening of the Open Source Malaria Box Reveals an Early Lead Compound for the Treatment of Alveolar Echinococcosis
Britta Stadelmann et al.
PLOS NEGLECTED TROPICAL DISEASES (2016)
The Surgical Treatment of Mycetoma
Suleiman Hussein Suleiman et al.
PLOS NEGLECTED TROPICAL DISEASES (2016)
Structure-activity studies of Wnt/β-catenin inhibition in the Niclosamide chemotype: Identification of derivatives with improved drug exposure
Robert A. Mook et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2015)
Significantly enhanced bioavailability of niclosamide through submicron lipid emulsions with or without PEG-lipid: a comparative study
Xingwang Zhang et al.
JOURNAL OF MICROENCAPSULATION (2015)
Eumycetoma and actinomycetoma - an update on causative agents, epidemiology, pathogenesis, diagnostics and therapy
P. Nenoff et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2015)
Repurposing Salicylanilide Anthelmintic Drugs to Combat Drug Resistant Staphylococcus aureus
Rajmohan Rajamuthiah et al.
PLOS ONE (2015)
Ex Vivo Activity of Endoperoxide Antimalarials, Including Artemisone and Arterolane, against Multidrug-Resistant Plasmodium falciparum Isolates from Cambodia
Charlotte A. Lanteri et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Niclosamide ethanolamine-induced mild mitochondrial uncoupling improves diabetic symptoms in mice
Hanlin Tao et al.
NATURE MEDICINE (2014)
Revision of agents of black-grain eumycetoma in the order Pleosporales
S. A. Ahmed et al.
PERSOONIA (2014)
New Life for an Old Drug: the Anthelmintic Drug Niclosamide Inhibits Pseudomonas aeruginosa Quorum Sensing
Francesco Imperi et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
The Open Access Malaria Box: A Drug Discovery Catalyst for Neglected Diseases
Thomas Spangenberg et al.
PLOS ONE (2013)
Redox-Active Antiparasitic Drugs
Chinmay Pal et al.
ANTIOXIDANTS & REDOX SIGNALING (2012)
1-Aryl-4-nitro-1H-imidazoles, a new promising series for the treatment of human African trypanosomiasis
Bernadette Bourdin Trunz et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2011)
Clonorchicidal properties of the synthetic trioxolane OZ78
Jennifer Keiser et al.
JOURNAL OF PARASITOLOGY (2007)
In vitro and in vivo activities of synthetic trioxolanes against major human schistosome species
Shu-Hua Xiao et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
In vitro susceptibility of Madurella mycetomatis, prime agent of Madura foot, to tea tree oil and artemisinin
Wendy W. J. van de Sande et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
The synthetic peroxide OZ78 is effective against Echinostoma caproni and Fasciola hepatica
Jennifer Keiser et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)
Identification of an antimalarial synthetic trioxolane drug development candidate
JL Vennerstrom et al.
NATURE (2004)
Inhibition of severe acute respiratory syndrome coronavirus replication by niclosamide
CJ Wu et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Share Paper
